Dalteparin Pfizer 2500 I.E./0,2 ml Գերմանիա - գերմաներեն - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

dalteparin pfizer 2500 i.e./0,2 ml

pfizer pharma gmbh (8075658) - dalteparin-natrium ((mw: ca. 6000)) - injektionslösung - teil 1 - injektionslösung; dalteparin-natrium ((mw: ca. 6000)) (26756) 2500 i.e. anti-blutgerinnungsfaktor xa aktivität

Dalteparin Pfizer 5000 I.E./0,2 ml Գերմանիա - գերմաներեն - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

dalteparin pfizer 5000 i.e./0,2 ml

pfizer pharma gmbh (8075658) - dalteparin-natrium ((mw: ca. 6000)) - injektionslösung - teil 1 - injektionslösung; dalteparin-natrium ((mw: ca. 6000)) (26756) 5000 i.e. anti-blutgerinnungsfaktor xa aktivität

Pemetrexed Pfizer (previously Pemetrexed Hospira) Եվրոպական Միություն - գերմաներեն - EMA (European Medicines Agency)

pemetrexed pfizer (previously pemetrexed hospira)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastische mittel - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.